Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines Inc (NQ: RVMD )

26.75 +0.93 (+3.58%)
Streaming Delayed Price Updated: 12:44 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 359,572
Open 25.95
Bid (Size) 26.75 (2)
Ask (Size) 26.77 (1)
Prev. Close 25.82
Today's Range 25.75 - 27.00
52wk Range 15.63 - 31.37
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Revolution Medicines Earnings Preview
 
Via Benzinga
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is... 
Via Benzinga

Performance

YTD
+16.54%
+16.54%
1 Month
+9.43%
+9.43%
3 Month
+7.24%
+7.24%
6 Month
+9.97%
+9.97%
1 Year
+40.62%
+40.62%

More News

Read More
Where Revolution Medicines Stands With Analysts
Via Benzinga
$140M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Why Revolution Medicines Stock Is Trading Lower
Via Benzinga
Why Revolution Medicines Shares Are Trading Higher Today
Via Benzinga
Revolution Medicines Earnings Preview
Via Benzinga
Where Revolution Medicines Stands With Analysts
Via Benzinga
Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst
Via Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Via Benzinga
Earnings Scheduled For February 27, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
Via Benzinga
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
Via Benzinga
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
From Revolution Medicines, Inc.
Via GlobeNewswire
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
Earnings Scheduled For November 7, 2022
Via Benzinga
Earnings Outlook For Revolution Medicines
Via Benzinga
$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
Via Benzinga
Revolution Medicines Stock Is Getting Hammered: Here's Why
Via Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
Via Benzinga
Earnings Scheduled For August 9, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.